Illumina (ILMN) Stock Forecast & Price Target

Compare

4,443 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ILMN Analyst Ratings

Moderate Buy

8 Buy

7 Hold

2 Sell

Based on 17 analysts giving stock ratings to

Illumina

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ILMN Stock 12 Month Forecast

Average Price Target

$108.13

▲(20.86%Upside)

Based on 17 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is $108.13 with a high forecast of $185.00 and a low forecast of $75.00. The average price target represents a 20.86% change from the last price of $89.47.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"74":"$74","102":"$102","130":"$130","158":"$158","186":"$186"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":185,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$185.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":108.13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$108.13</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$75.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[74,102,130,158,186],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.09,89.08307692307693,97.07615384615384,105.06923076923077,113.0623076923077,121.05538461538461,129.04846153846154,137.04153846153847,145.0346153846154,153.0276923076923,161.02076923076925,169.01384615384615,177.00692307692307,{"y":185,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.09,83.17,85.25,87.33,89.41,91.49,93.57,95.65,97.72999999999999,99.81,101.88999999999999,103.97,106.05,{"y":108.13,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.09,80.62153846153846,80.15307692307692,79.68461538461538,79.21615384615384,78.7476923076923,78.27923076923076,77.81076923076924,77.3423076923077,76.87384615384616,76.40538461538462,75.93692307692308,75.46846153846154,{"y":75,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":101.34,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":105.5,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":122.35,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.4,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":128.98,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":149.76,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.15,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.63,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":132.74,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.74,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.39,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.51,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.09,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$185.00

Average Price Target$108.13

Lowest Price Target$75.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$84

Hold

-6.11%

Downside

Reiterated

06/05/25

Illumina's stock score reflects significant financial challenges due to operational inefficiencies and declining revenues, despite strong gross margins. Technical analysis provides mixed signals with short-term bullish momentum but long-term bearish trends. The company's valuation is weak due to a negative P/E ratio, underscoring the need for financial improvement. Earnings call highlights some promising developments, but geopolitical and economic headwinds pose substantial risks.

Kyle Mikson CFACanaccord Genuity

Canaccord Genuity

$87→$99

Hold

10.65%

Upside

Reiterated

06/10/25

Canaccord Genuity Remains a Hold on Illumina (ILMN)

David WestenbergPiper Sandler

Piper Sandler

$185

Buy

106.77%

Upside

Reiterated

06/09/25

Piper Sandler Remains a Buy on Illumina (ILMN)

Conor McNamaraRBC Capital

RBC Capital

$112→$115

Buy

28.53%

Upside

Reiterated

06/05/25

Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and Medtronic (NYSE: MDT)

Daniel AriasStifel Nicolaus

Stifel Nicolaus

$135

Buy

50.89%

Upside

Reiterated

05/28/25

Illumina (ILMN) Receives a Buy from Stifel Nicolaus

Puneet SoudaLeerink Partners

Leerink Partners

―

Buy

―

Reiterated

05/27/25

Illumina: Strong Market Position and Value Opportunity Amidst Emerging Competition

Unknown AnalystStephens

Not Ranked

Stephens

$105

Buy

17.36%

Upside

Reiterated

05/20/25

Dan LeonardUBS

UBS

$145→$98

Hold

9.53%

Upside

Reiterated

05/14/25

Illumina price target lowered to $98 from $145 at UBSIllumina price target lowered to $98 from $145 at UBS

Tejas SavantMorgan Stanley

Morgan Stanley

$100

Hold

11.77%

Upside

Reiterated

05/12/25

Illumina's Hold Rating Amidst Strong Instrument Sales and Challenges in Chinese Market

Daniel BrennanTD Cowen

TD Cowen

$86→$89

Hold

-0.53%

Downside

Reiterated

05/09/25

TD Cowen Reaffirms Their Hold Rating on Illumina (ILMN)

Rachel VatnsdalJ.P. Morgan

J.P. Morgan

$120→$85

Hold

-5.00%

Downside

Reiterated

05/09/25

Illumina price target lowered to $85 from $120 at JPMorganIllumina price target lowered to $85 from $120 at JPMorgan

Subbu NambiGuggenheim

Guggenheim

$122→$114

Buy

27.42%

Upside

Reiterated

05/09/25

Illumina price target lowered to $114 from $122 at GuggenheimIllumina price target lowered to $114 from $122 at Guggenheim

Luke SergottBarclays

Barclays

$77

Sell

-13.94%

Downside

Reiterated

05/09/25

Barclays Remains a Sell on Illumina (ILMN)

Patrick B DonnellyCiti

Citi

$85

Hold

-5.00%

Downside

Reiterated

05/08/25

Illumina's Financial Outlook: Hold Rating Amidst Export Bans and Tariff Challenges

Eve BursteinBernstein

Bernstein

―

Hold

―

Reiterated

05/05/25

Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (NASDAQ: JANX) and Illumina (NASDAQ: ILMN)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$84

Hold

-6.11%

Downside

Reiterated

06/05/25

Kyle Mikson CFACanaccord Genuity

Canaccord Genuity

$87→$99

Hold

10.65%

Upside

Reiterated

06/10/25

Canaccord Genuity Remains a Hold on Illumina (ILMN)

David WestenbergPiper Sandler

Piper Sandler

$185

Buy

106.77%

Upside

Reiterated

06/09/25

Piper Sandler Remains a Buy on Illumina (ILMN)

Conor McNamaraRBC Capital

RBC Capital

$112→$115

Buy

28.53%

Upside

Reiterated

06/05/25

Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and Medtronic (NYSE: MDT)

Daniel AriasStifel Nicolaus

Stifel Nicolaus

$135

Buy

50.89%

Upside

Reiterated

05/28/25

Illumina (ILMN) Receives a Buy from Stifel Nicolaus

Puneet SoudaLeerink Partners

Leerink Partners

―

Buy

―

Reiterated

05/27/25

Illumina: Strong Market Position and Value Opportunity Amidst Emerging Competition

Unknown AnalystStephens

Not Ranked

Stephens

$105

Buy

17.36%

Upside

Reiterated

05/20/25

Dan LeonardUBS

UBS

$145→$98

Hold

9.53%

Upside

Reiterated

05/14/25

Illumina price target lowered to $98 from $145 at UBSIllumina price target lowered to $98 from $145 at UBS

Tejas SavantMorgan Stanley

Morgan Stanley

$100

Hold

11.77%

Upside

Reiterated

05/12/25

Illumina's Hold Rating Amidst Strong Instrument Sales and Challenges in Chinese Market

Daniel BrennanTD Cowen

TD Cowen

$86→$89

Hold

-0.53%

Downside

Reiterated

05/09/25

TD Cowen Reaffirms Their Hold Rating on Illumina (ILMN)

Rachel VatnsdalJ.P. Morgan

J.P. Morgan

$120→$85

Hold

-5.00%

Downside

Reiterated

05/09/25

Illumina price target lowered to $85 from $120 at JPMorganIllumina price target lowered to $85 from $120 at JPMorgan

Subbu NambiGuggenheim

Guggenheim

$122→$114

Buy

27.42%

Upside

Reiterated

05/09/25

Illumina price target lowered to $114 from $122 at GuggenheimIllumina price target lowered to $114 from $122 at Guggenheim

Luke SergottBarclays

Barclays

$77

Sell

-13.94%

Downside

Reiterated

05/09/25

Barclays Remains a Sell on Illumina (ILMN)

Patrick B DonnellyCiti

Citi

$85

Hold

-5.00%

Downside

Reiterated

05/08/25

Illumina's Financial Outlook: Hold Rating Amidst Export Bans and Tariff Challenges

Eve BursteinBernstein

Bernstein

―

Hold

―

Reiterated

05/05/25

Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (NASDAQ: JANX) and Illumina (NASDAQ: ILMN)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Illumina

1 Month

xxx

Success Rate

14/25 ratings generated profit

Average Return

+0.87%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 56.00% of your transactions generating a profit, with an average return of +0.87% per trade.

3 Months

xxx

Success Rate

14/25 ratings generated profit

Average Return

+1.11%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 56.00% of your transactions generating a profit, with an average return of +1.11% per trade.

1 Year

Doug SchenkelWolfe Research

Success Rate

24/32 ratings generated profit

Average Return

+15.88%

reiterated a buy rating 4 months ago

Copying Doug Schenkel's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +15.88% per trade.

2 Years

xxx

Success Rate

17/25 ratings generated profit

Average Return

+9.87%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 68.00% of your transactions generating a profit, with an average return of +9.87% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ILMN Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ILMN has received 16 Buy Ratings, 13 Hold Ratings, and 3 Sell Ratings. ILMN average Analyst price target in the past 3 months is 108.13.

Each month's total comprises the sum of three months' worth of ratings.

ILMN Financial Forecast

ILMN Earnings Forecast

Next quarter’s earnings estimate for ILMN is $1.01 with a range of $0.97 to $1.04. The previous quarter’s EPS was $0.97. ILMN beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 43.18% of the time in the same period. In the last calendar year ILMN has Outperformed its overall industry.

ILMN Sales Forecast

Next quarter’s sales forecast for ILMN is $1.05B with a range of $1.04B to $1.06B. The previous quarter’s sales results were $1.04B. ILMN beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 56.92% of the time in the same period. In the last calendar year ILMN has Outperformed its overall industry.

ILMN Stock Forecast FAQ

What is ILMN’s average 12-month price target, according to analysts?

Based on analyst ratings, Illumina’s 12-month average price target is 108.13.

What is ILMN’s upside potential, based on the analysts’ average price target?

Illumina has 20.86% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ILMN a Buy, Sell or Hold?

Illumina has a consensus rating of Moderate Buy which is based on 8 buy ratings, 7 hold ratings and 2 sell ratings.

What is Illumina’s price target?

The average price target for Illumina is 108.13. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $185.00 ,the lowest forecast is $75.00. The average price target represents 20.86% Increase from the current price of $89.47.

What do analysts say about Illumina?

Illumina’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.

How can I buy shares of ILMN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Illumina (ILMN) Stock Forecast & Price Target

ILMN Analyst Ratings

ILMN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Illumina

ILMN Analyst Recommendation Trends

ILMN Financial Forecast

ILMN Earnings Forecast

ILMN Sales Forecast

ILMN Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts